Search research articles
Contact Us
Filters
Showing results (1-10 of 79) with videos related to
Page
of 8
Sort By:
European Journal of Clinical Pharmacology
|
April 6, 2011
Early phase drugs and biologicals clinical trials on worldwide leading causes of death: a descriptive analysis
Rafael Dal-Ré
Expert Review of Clinical Pharmacology
|
August 16, 2020
Ongoing non-industry-sponsored COVID-19 clinical trials in the first trimester of the pandemic: significant differences between the European and the USA approaches
Rafael Dal-Ré
European Journal of Clinical Pharmacology
|
May 25, 2020
Articles provided insufficient information to conduct an appropriate retrospective assessment of the pragmatic/explanatory features of medicine trials with the PRECIS-2 tool
Rafael Dal-Ré
Trends in Pharmacological Sciences
|
August 2, 2016
Are the Most Prestigious Medical Journals Transparent Enough?
Rafael Dal-Ré
Trends in Pharmacological Sciences
|
January 19, 2015
Improving transparency of clinical trials
Rafael Dal-Ré
European Journal of Clinical Investigation
|
October 27, 2016
The International Committee of Medical Journal Editors trial data sharing requirement and participants' consent
Rafael Dal-Ré
Enfermedades Infecciosas Y Microbiologia Clinica
|
July 15, 2015
[Is it ethically acceptable to invite a pregnant woman to enroll in a clinical trial with Tdap if it could entail not being vaccinated with Tdap before delivery?]
Rafael Dal-Ré
Medicina Clinica
|
June 27, 2019
Analysis of biomedical Spanish articles retracted between 1970 and 2018
Rafael Dal-Ré
Journal of Evaluation in Clinical Practice
|
July 8, 2017
Could phase 3 medicine trials be tagged as pragmatic? A case study: The Salford COPD trial
Rafael Dal-Ré
Health Education & Behavior : the Official Publication of the Society for Public Health Education
|
May 12, 2011
Worldwide behavioral research on major global causes of mortality
Rafael Dal-Ré
Page
of 8
Search research articles
Search
Showing results (1-10 of 79) with videos related to
Sort By:
Page
of 8
European Journal of Clinical Pharmacology
|
April 6, 2011
Early phase drugs and biologicals clinical trials on worldwide leading causes of death: a descriptive analysis
Rafael Dal-Ré
Expert Review of Clinical Pharmacology
|
August 16, 2020
Ongoing non-industry-sponsored COVID-19 clinical trials in the first trimester of the pandemic: significant differences between the European and the USA approaches
Rafael Dal-Ré
European Journal of Clinical Pharmacology
|
May 25, 2020
Articles provided insufficient information to conduct an appropriate retrospective assessment of the pragmatic/explanatory features of medicine trials with the PRECIS-2 tool
Rafael Dal-Ré
Trends in Pharmacological Sciences
|
August 2, 2016
Are the Most Prestigious Medical Journals Transparent Enough?
Rafael Dal-Ré
Trends in Pharmacological Sciences
|
January 19, 2015
Improving transparency of clinical trials
Rafael Dal-Ré
European Journal of Clinical Investigation
|
October 27, 2016
The International Committee of Medical Journal Editors trial data sharing requirement and participants' consent
Rafael Dal-Ré
Enfermedades Infecciosas Y Microbiologia Clinica
|
July 15, 2015
[Is it ethically acceptable to invite a pregnant woman to enroll in a clinical trial with Tdap if it could entail not being vaccinated with Tdap before delivery?]
Rafael Dal-Ré
Medicina Clinica
|
June 27, 2019
Analysis of biomedical Spanish articles retracted between 1970 and 2018
Rafael Dal-Ré
Journal of Evaluation in Clinical Practice
|
July 8, 2017
Could phase 3 medicine trials be tagged as pragmatic? A case study: The Salford COPD trial
Rafael Dal-Ré
Health Education & Behavior : the Official Publication of the Society for Public Health Education
|
May 12, 2011
Worldwide behavioral research on major global causes of mortality
Rafael Dal-Ré
Page
of 8